In addition, it would be important to compare results with RMD patients treated with anti-CD20 antibody in a dedicated study, since this cohort was under-represented in our study
In addition, it would be important to compare results with RMD patients treated with anti-CD20 antibody in a dedicated study, since this cohort was under-represented in our study. Anti-TNF drugs neutralize a major component of the cytokine response that is part of the damaging excess inflammatory phase of COVID-19. This study provides a whole picture…